HighVista Strategies »

Structure Therapeutics shares owned by HighVista Strategies

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.8M 75k 50.42

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Activision Blizzard
Vmware Cl A Com
Albertsons Cos Common Stock (ACI)
Immunovant (IMVT)
Capri Holdings SHS (CPRI)
Horizon Therapeutics Pub L SHS
stock
Seagen
Axsome Therapeutics (AXSM)
Structure Therapeutics Sponsored Ads (GPCR)
Amedisys (AMED)
Ideaya Biosciences (IDYA)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Microsoft Corporation (MSFT)

View all positions for HighVista Strategies

Top funds holding Structure Therapeutics

Wellington Management Company
venBio Select Advisor
Federated Investors
Avidity Partners Management
T. Rowe Price Associates
Henderson Group
Citadel Advisors
Casdin Capital
Logos Global Management
Sc China Holding
Deerfield Management Company
BVF
Caption Management
Franklin Resources
RA Capital Management

View all funds holding Structure Therapeutics